1. Home
  2. KRYS vs NNI Comparison

KRYS vs NNI Comparison

Compare KRYS & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • NNI
  • Stock Information
  • Founded
  • KRYS 2015
  • NNI 1978
  • Country
  • KRYS United States
  • NNI United States
  • Employees
  • KRYS N/A
  • NNI N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • NNI Finance: Consumer Services
  • Sector
  • KRYS Health Care
  • NNI Finance
  • Exchange
  • KRYS Nasdaq
  • NNI Nasdaq
  • Market Cap
  • KRYS 4.3B
  • NNI 4.2B
  • IPO Year
  • KRYS 2017
  • NNI 2003
  • Fundamental
  • Price
  • KRYS $153.22
  • NNI $124.92
  • Analyst Decision
  • KRYS Strong Buy
  • NNI Hold
  • Analyst Count
  • KRYS 11
  • NNI 1
  • Target Price
  • KRYS $204.27
  • NNI $98.00
  • AVG Volume (30 Days)
  • KRYS 273.0K
  • NNI 95.4K
  • Earning Date
  • KRYS 08-04-2025
  • NNI 08-06-2025
  • Dividend Yield
  • KRYS N/A
  • NNI 0.90%
  • EPS Growth
  • KRYS 109.01
  • NNI 44.75
  • EPS
  • KRYS 4.16
  • NNI 5.30
  • Revenue
  • KRYS $333,448,000.00
  • NNI $1,365,360,000.00
  • Revenue This Year
  • KRYS $40.10
  • NNI $14.91
  • Revenue Next Year
  • KRYS $49.73
  • NNI $5.52
  • P/E Ratio
  • KRYS $36.72
  • NNI $23.54
  • Revenue Growth
  • KRYS 247.53
  • NNI 9.48
  • 52 Week Low
  • KRYS $122.80
  • NNI $98.15
  • 52 Week High
  • KRYS $212.06
  • NNI $127.32
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 60.29
  • NNI 63.59
  • Support Level
  • KRYS $147.35
  • NNI $123.90
  • Resistance Level
  • KRYS $154.99
  • NNI $126.49
  • Average True Range (ATR)
  • KRYS 4.27
  • NNI 2.55
  • MACD
  • KRYS 0.11
  • NNI 0.21
  • Stochastic Oscillator
  • KRYS 69.85
  • NNI 76.50

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About NNI Nelnet Inc.

Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.

Share on Social Networks: